“⚖[O1OV5735V2065] 울산노래방 울산삼산동노래방1 울산노래방. 삼산동노래방S 울산풀싸롱Q 울산룸싸롱 삼산동룸싸롱V 삼산동풀싸롱A⚖”的搜索结果，显示 21-30 项，共有 7688 项

1. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

2. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

3. 住院内科- 临床试验- 妙佑医疗国际

   The primary purpose of this study is to examine 1-year survival and rate of secondary infections in COVID-19 patients with and without acute kidney injury (AKI) ...

4. 医生 - 妙佑医疗国际儿童中心 - 妙佑医疗国际儿童中心

   Ahmed, M.D.. Phoenix, AZ. Edward S. Ahn, M.D.. Rochester, MN.

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

7. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

8. 医生 - 检验医学与病理学- 妙佑医疗国际

   Hussam Al Kateb, Ph.D. Rochester, MN. Sam T. Albadri, M.B., Ch.B. Rochester, MN. Priya P. Alexander, M.D.. Rochester, MN. Alicia Algeciras-Schimnich, Ph.D.

9. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   The purpose of this study is to identify a biomarker (or biomarkers) that is present when disease is present (i.e., at diagnosis or recurrence) and not ...

10. 《无意外账单法案》 - 妙佑医疗国际

    ... 1, 2022. The provisions in the NSA create requirements such as cost-sharing rules, prohibitions on balance billing for certain services, notice and consent ...